What’s New in Photon Counting CT?

August 14, 2026 · 7 articles · 8 research themes · covering August 07, 2026 – August 14, 2026

Overview

Across this week’s set of studies, photon-counting CT (PCCT/PCD-CT) is being pushed along two parallel tracks: (1) translating spectral/iodine quantification into clinically actionable imaging, and (2) optimizing acquisition and reconstruction physics to make those measurements more accurate and dose-efficient.

Clinically, multiple cardiac-focused papers suggest that PCCT’s iodine-based metrics may better reflect disease severity and tissue characterization than conventional approaches. In coronary CT angiography, myocardial iodine attenuation and iodine/virtual non-contrast ratios tracked with CAD-RADS stenosis severity in the LAD territory, pointing toward PCCT-derived quantitative biomarkers that complement anatomical grading. For ischemic myocardial scar assessment, iodine maps derived from PCCT improved quantitative image quality and reader confidence for late iodine enhancement, supporting the idea that more reliable iodine quantification could strengthen scar evaluation.

Outside cardiology, PCCT is also showing promise for targeted diagnostic tasks where conventional imaging can be challenging. In primary hyperparathyroidism, photon-counting detector 4D CT demonstrated diagnostic performance for localizing abnormal parathyroid tissue, with potential benefit for ectopic disease and minimally invasive surgery planning. In EVAR surveillance, a phantom study identified the lowest radiation dose that still preserved high detectability of small iodinated endoleaks, providing a practical dose-reduction target for lifelong follow-up.

Underpinning these clinical directions, a physics study highlighted that x-ray pre-filtration choices materially affect spectral decomposition accuracy—and that optimal settings depend on both filter properties and the atomic number/composition of target materials (low-Z iodine/barium vs high-Z tantalum). Finally, a narrative update on French research emphasizes ongoing translation of spectral/PCCT innovations and AI into real workflows, framing these technical and clinical advances as part of a broader implementation roadmap.

---

Photon-counting CT clinical performance (comparative/real-world)

Clinical Photon-Counting CT in Neuroradiology: A Real-World Paired Comparison with Conventional Energy-Integrating CT.

This retrospective real-world paired comparison studied clinical photon-counting CT (PCCT) versus conventional energy-integrating detector CT (EID-CT) in routine neuroradiology examinations in patients undergoing paired brain imaging. PCCT was evaluated for image quality, pathology conspicuity, and radiation dose efficiency across heterogeneous scanner generations and reconstruction/protocol differences, with the study hypothesis that PCCT would improve image-quality and lesion conspicuity while reducing dose for comparable diagnostic performance. If confirmed, these pragmatic clinical data would support broader adoption of PCCT in neuroradiology by demonstrating dose-efficient improvements over existing EID-CT systems in everyday practice.

Szum A, Moberg F, Kalarakis G et al. · AJNR. American journal of neuroradiology · (2026) · View on PubMed ↗

---

Photon-counting CT spectral quantification & material decomposition physics

Material-dependent effects of x-ray pre-filtration on material decomposition in photon-counting CT.

This physics study characterized how x-ray pre-filtration affects material decomposition (MD) performance in photon-counting CT (PCCT) using single-contrast phantoms of iodine, barium, and tantalum and a dual-contrast iodine–tantalum phantom on a CdZnTe PCCT system. The key finding was that MD accuracy depends on both the filter material/thickness and the atomic number/composition of the target materials, with different pre-filtration conditions producing different decomposition performance for low-Z (iodine, barium) versus high-Z (tantalum) contrast. Scientifically, these results inform how to choose or optimize pre-filtration to improve spectral quantification and reduce bias in PCCT-based material mapping.

Aubrey JD, Perkinson EP, Wang G et al. · Physics in medicine and biology · (2026) · View on PubMed ↗

---

Photon-counting CT cardiac coronary imaging (iodine metrics/stenosis)

Myocardial iodine attenuation is associated with coronary artery stenosis severity: insights from photon-counting CT.

This retrospective single-center clinical study assessed whether myocardial iodine attenuation and iodine/virtual non-contrast (VNC) ratios from photon-counting CT (PCCT) correlate with coronary artery stenosis severity classified by CAD-RADS in 57 patients undergoing clinically indicated coronary CT angiography. The key finding was that higher myocardial iodine attenuation (and related iodine/VNC metrics) was associated with more severe coronary stenosis in the left anterior descending (LAD) myocardial territory. If validated, PCCT-derived iodine metrics could add functional/biochemical information to anatomical stenosis grading for improved risk stratification in coronary artery disease.

Langenbach MC, Rippel K, Brendel JM et al. · The international journal of cardiovascular imaging · (2026) · View on PubMed ↗

---

Photon-counting CT myocardial scar & late iodine enhancement

Photon-counting CT iodine maps for late iodine enhancement: a retrospective feasibility study of image quality and reader confidence.

This retrospective feasibility study investigated whether photon-counting detector CT (PCD-CT) iodine maps can improve late iodine enhancement (LIE) imaging for ischemic-type myocardial scar assessment in patients evaluated for coronary artery disease. The key finding was that PCD-CT-derived iodine maps provided measurable quantitative image quality and improved reader confidence for LIE compared with the limitations of conventional late iodine enhancement CT. If reproducible, this would support PCCT as a more reliable platform for myocardial scar characterization using iodine-based quantification.

Hartung V, Gruschwitz P, Serfling JK et al. · European radiology experimental · (2026) · View on PubMed ↗ · Free PDF ↗

---

Photon-counting CT preoperative localization (parathyroid)

Photon-Counting Detector 4D CT for Preoperative Localization in Primary Hyperparathyroidism.

This ambispective clinical study evaluated photon-counting detector 4D CT (PCD-CT) for preoperative localization of abnormal parathyroid tissue in 36 patients with primary hyperparathyroidism undergoing preoperative 4D PCD-CT followed by parathyroidectomy. The key finding was the diagnostic performance of PCD-CT for localizing parathyroid lesions, compared against available ultrasound and Tc-99m sestamibi scintigraphy results in most patients. Clinically, improved localization—especially in ectopic disease where conventional imaging can fail—could increase the success rate of minimally invasive parathyroidectomy.

Huls SJ, Burkett BJ, Yu L et al. · AJNR. American journal of neuroradiology · (2026) · View on PubMed ↗ · Free PDF ↗

---

Photon-counting CT endovascular imaging (EVAR/endoleaks)

Endoleak detection with photon-counting detector CT at various radiation doses after endovascular aneurysm repair: a phantom study.

This phantom study evaluated photon-counting detector CT (PCD-CT) for endoleak detection after endovascular aneurysm repair across radiation doses (100%, 50%, 25%, 12.5%) using 55 keV and 50 keV virtual monoenergetic images (VMIs) in an abdominal aneurysm phantom. The key finding was the identification of the lowest radiation dose that still maintained high detectability of small (2–6 mm) iodinated endoleaks when reconstructing 50 keV VMI at reduced dose levels. Clinically, this provides a dose-reduction target for lifelong post-EVAR surveillance CT while preserving sensitivity for tiny endoleaks.

Huber AT, Szucs-Farkas G, Perrin LG et al. · The international journal of cardiovascular imaging · (2026) · View on PubMed ↗

---

Photon-counting CT technology landscape & AI/systems roadmap

Imaging in France: 2026 Update.

This narrative update article summarized selected radiology research initiatives and technological advances in France as of 2026, including developments in dual-energy and photon-counting computed tomography and applications of artificial intelligence. The key finding is that French research groups are actively translating innovations in spectral/PCCT imaging and AI into diagnostic and interventional radiology workflows. Scientifically and clinically, it provides a high-level roadmap of emerging directions that may shape future PCCT adoption and research priorities.

Talabard MP, Greffier J, Calame P et al. · Canadian Association of Radiologists journal = Journal l’Association canadienne des radiologistes · (2026) · View on PubMed ↗

---

---

Generated automatically on August 14, 2026. Covers PubMed articles published August 07, 2026 – August 14, 2026. Summaries are AI-generated; always consult the original publication for clinical or research decisions.